NCT00627575View on ClinicalTrials.gov

AED/Statin Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

February 4, 2008

Primary Completion Date

September 12, 2008

Study Completion Date

September 12, 2008

Conditions
Epilepsy
Interventions
DRUG

lamotrigine

Lamotrigine tablets will be available in 25, 50, 100 and 200 mg dose strength.

DRUG

atorvastatin

Atorvastatin will available as 40 mg tablets.

DRUG

phenytoin

Phenytoin will available as 100 mg capsules.

Trial Locations (1)

14202

GSK Investigational Site, Buffalo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00627575 - AED/Statin Interaction Study | Biotech Hunter | Biotech Hunter